Marcelo H Napimoga1, Regiane Yatsuda. 1. Laboratory of Biopathology and Molecular Biology, University of Uberaba, Minas Gerais 38055-500, Brazil. marcelo.napimoga@uniube.br
Abstract
OBJECTIVES: Historically, the majority of new drugs have been generated from natural products as well as from compounds derived from natural products. In this context, Mikania laevigata and M. glomerata, popularly known as 'guaco', have a long history of use. Brazilian Indians have an ancient tradition of using 'guaco' for snakebites. In current herbal medicine in Brazil, 'guaco' is used as an effective natural bronchodilator, expectorant and cough suppressant employed for all types of upper respiratory problems including bronchitis, pleurisy, colds and flu, coughs and asthma. KEY FINDINGS: In Brazil, this plant has been widely used, even as commercial preparations. Its medicinal properties are widely recognized, mainly in the treatment of inflammatory conditions, bronchodilator activity, anti-ulcerogenic, antiophidian as well as antibacterial and antiparasitic activity, although the efficacy of the antibacterial activity is so far controversial. SUMMARY: The studies on Mikania glomerata and M. laevigata have provided scientific evidence that those plants have a considerable anti-inflammatory therapeutic potential.
OBJECTIVES: Historically, the majority of new drugs have been generated from natural products as well as from compounds derived from natural products. In this context, Mikania laevigata and M. glomerata, popularly known as 'guaco', have a long history of use. Brazilian Indians have an ancient tradition of using 'guaco' for snakebites. In current herbal medicine in Brazil, 'guaco' is used as an effective natural bronchodilator, expectorant and cough suppressant employed for all types of upper respiratory problems including bronchitis, pleurisy, colds and flu, coughs and asthma. KEY FINDINGS: In Brazil, this plant has been widely used, even as commercial preparations. Its medicinal properties are widely recognized, mainly in the treatment of inflammatory conditions, bronchodilator activity, anti-ulcerogenic, antiophidian as well as antibacterial and antiparasitic activity, although the efficacy of the antibacterial activity is so far controversial. SUMMARY: The studies on Mikania glomerata and M. laevigata have provided scientific evidence that those plants have a considerable anti-inflammatory therapeutic potential.
Authors: Luciana Soares E Soares e Silva; Luciane Santos da Santos da Silva; Larissa Brumano; Paulo César Stringheta; Miriam Aparecida de Oliveira Pinto; Leticia Oliveira Moreira Dias; Camila de Sá Martins Muller; Elita Scio; Rodrigo Luiz Fabri; Helena C Castro; Maria da Penha Henriques do Amaral Journal: Molecules Date: 2012-08-29 Impact factor: 4.411
Authors: Lucas Amaral-Machado; Wógenes N Oliveira; Susiane S Moreira-Oliveira; Daniel T Pereira; Éverton N Alencar; Nicolas Tsapis; Eryvaldo Sócrates T Egito Journal: Evid Based Complement Alternat Med Date: 2020-02-13 Impact factor: 2.629
Authors: François Chassagne; Tharanga Samarakoon; Gina Porras; James T Lyles; Micah Dettweiler; Lewis Marquez; Akram M Salam; Sarah Shabih; Darya Raschid Farrokhi; Cassandra L Quave Journal: Front Pharmacol Date: 2021-01-08 Impact factor: 5.810
Authors: Lorena C L R Santana; Maria R M Brito; George L S Oliveira; Antônia M G L Citó; Clayton Q Alves; Juceni P David; Jorge M David; Rivelilson M de Freitas Journal: Evid Based Complement Alternat Med Date: 2014-08-18 Impact factor: 2.629